Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Takuto Yamashita"'
Autor:
Teppei Yamada, Koichi Azuma, Emi Muta, Jintaek Kim, Shunichi Sugawara, Guang Lan Zhang, Satoko Matsueda, Yuri Kasama-Kawaguchi, Yuichi Yamashita, Takuto Yamashita, Kazuto Nishio, Kyogo Itoh, Tomoaki Hoshino, Tetsuro Sasada
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78389 (2013)
Treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, has achieved high clinical response rates in patients with non-small cell lung cancers (NSCLCs). However, over time, most tumors
Externí odkaz:
https://doaj.org/article/f20128da8f634f9797a1405c8daa00ff
Autor:
Atsushi Satomura, Yoichi Oikawa, Haruhiko Sato, Sotaro Takagi, Takuto Yamashita, Akira Shimada
Publikováno v:
Diabetology International. 14:109-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76cc9a91ef02669ffa318f09987cf4d4
https://doi.org/10.1007/s13340-022-00599-6
https://doi.org/10.1007/s13340-022-00599-6
Autor:
Hiroyasu Yamamoto, Takashi Yamada, Ken Miyazaki, Takuto Yamashita, Takuya Kato, Kenichi Ohara, Yusuke Nakamura, Tadao Akizawa
Publikováno v:
Clinical and Experimental Nephrology.
Background Erythropoiesis-stimulating agents (ESAs) are the standard treatment for patients with renal anemia to increase hemoglobin (Hb) levels and reduce the need for blood transfusions. However, treatments targeting high Hb levels require high dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9596bf10254252dcf7f8090cebcc0414
https://doi.org/10.1007/s10157-023-02353-x
https://doi.org/10.1007/s10157-023-02353-x
Autor:
Hiroyasu Yamamoto, Takashi Yamada, Ken Miyazaki, Takuto Yamashita, Takuya Kato, Kenichi Ohara, Yusuke Nakamura, Yoko Sakai, Bruce Crawford, Tadao Akizawa
Erythropoiesis-stimulating agents (ESAs) are a standard treatment for patients with renal anemia to increase hemoglobin (Hb) levels and reduce their need for blood transfusions. However, treatments targeting high Hb levels require high doses of ESAs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f4a257349dfb66a5f7a0f01555c73a6
https://doi.org/10.21203/rs.3.rs-2181269/v1
https://doi.org/10.21203/rs.3.rs-2181269/v1
Autor:
Masayasu Naito, Takahisa Shirahama, Koji Okuda, Tetsuro Sasada, Satoko Matsueda, Takuto Yamashita, Daisuke Muroya, Kyogo Itoh, Shigeki Shichijo, Akira Yamada, Shinjiro Sakamoto, Shigeru Yutani
Publikováno v:
Cancer Science
Since the prognosis of advanced biliary tract cancer (aBTC) still remains very poor, new therapeutic approaches, including immunotherapies, need to be developed. In the current study, we conducted an open-label randomized phase II study to test wheth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9541e7306e5a811ae676ec80d6a74d29
https://doi.org/10.1111/cas.13193
https://doi.org/10.1111/cas.13193
Autor:
Takuto Yamashita, Kiyoaki Nishihara, Shigeki Shichijo, Shigeru Yutani, Tsukasa Igawa, Shigetaka Suekane, Kyogo Itoh, Kousuke Ueda, Masanori Noguchi, Tetsuro Sasada, Noriko Koga
Publikováno v:
Cancer Science
This study investigated the applicability of personalized peptide vaccination (PPV) for patients with metastatic upper tract urothelial cancer (mUTUC) after failure of platinum-based chemotherapy. In this single arm, open-label, phase II clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444c898c414b346cdd72ffd77cad8012
https://pubmed.ncbi.nlm.nih.gov/28940789
https://pubmed.ncbi.nlm.nih.gov/28940789
Autor:
Shigetaka Suekane, Shigeki Shichijo, Masanori Noguchi, Takuto Yamashita, Shigeru Yutani, Kyogo Itoh, Kousuke Ueda, Tetsuro Sasada, Kiyoaki Nishihara, Tsukasa Igawa
Publikováno v:
Journal of Urology. 197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a622ef1832387181b32df6c603505b94
https://doi.org/10.1016/j.juro.2017.02.2094
https://doi.org/10.1016/j.juro.2017.02.2094
Autor:
Takuto Yamashita, Takashi Yanagawa
Publikováno v:
Bulletin of informatics and cybernetics. 45:45-57
An alternative to the Satterswaite-Welch degrees of freedom (df) is developed in this paper based on unbiased estimating equations. The method enables us to evaluate the impact of sample variation due to using estimated df instead of the true df by c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed876dc19ab14fe22336930036e06d63
https://doi.org/10.5109/1563531
https://doi.org/10.5109/1563531
Autor:
Nobukazu Komatsu, Masato Yokomine, Toshiharu Kamura, Ken Matsukuma, Kouichiro Kawano, Shigeki Shichijo, Akimasa Fukui, Takuto Yamashita, Kyogo Itoh, Tetsuro Sasada, Kazuto Tasaki, Kimio Ushijima, Satoko Matsueda
Publikováno v:
Experimental and therapeutic medicine 13(4):1500-1505, 2017
Currently prophylactic HPV16/18 L1 virus-like particle (VLP) vaccines are employed with great success for the prevention of HPV infection. However, limited information is available regarding the immune responses against human papillomavirus (HPV) 16/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f780e769599eea76bb09a82fb2a41728
https://pubmed.ncbi.nlm.nih.gov/28413500
https://pubmed.ncbi.nlm.nih.gov/28413500
Autor:
Munetsugu Hara, Toyojiro Matsuishi, Shinichiro Nagamitsu, Ikuhiko Shibuya, Takashi Ohya, Yuko Araki, Yushiro Yamashita, Takuto Yamashita, Tatsuyuki Kakuma, Chiho Iizuka
Publikováno v:
Brain and Development. 32:609-612
The aim of this research was to compare the Strengths and Difficulties Questionnaire (SDQ) scores and subscale scores in children with high-functioning autism spectrum disorder (HFASD) and attention-deficit/hyperactivity disorder (AD/HD), and also to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95e75992afca3fc90bcbcd68cf06c242
https://doi.org/10.1016/j.braindev.2009.09.009
https://doi.org/10.1016/j.braindev.2009.09.009